Clearlake Capital Acquires Perforce Software and ProVation Medical

Palo Alto – February 1, 2018 – Cooley advised Clearlake Capital on its recent acquisitions of leading software solutions companies Perforce Software and ProVation Medical. Cooley partner Mehdi Khodadad led the teams advising Clearlake on the transactions. 

Under the terms of the acquisition of Perforce Software from Summit Partners, the company will continue to be led by Janet Dryer, CEO, and Mark Ties, COO, who will join the board of directors alongside Clearlake representatives. “This announcement represents another major milestone in our transformation of Perforce,” said Dryer in a recent news release. Ties added that he expects “Clearlake’s deep software experience and its proved ability to help companies grow will provide invaluable support as we continue to broaden our development operations solutions, expand internationally and pursue acquisition strategy.”

Perforce Software is the developer of the industry’s most flexible, scalable and secure version control and collaboration platform. Enterprises across the globe rely on Perforce to build and deliver digital products faster and with higher quality.

The second transaction is a carve-out buyout of ProVation Medical from Netherlands-based conglomerate Wolters Kluwer NV. ProVation Medical is a market-leader in procedure documentation and order set management software solutions. Hospitals and ambulatory surgery centers use ProVation solutions to improve their coding accuracy, eliminate transcription costs and consolidate financial, clinical and administrative tasks. 

Cooley has a longstanding relationship with Clearlake, advising the firm on various transactions and portfolio matters since 2011.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.